Home » Newsletters » BioWorld

BioWorld

April 27, 2000

View Archived Issues

Celgene In $100M-Plus Deal With Novartis For Attenade

Ruling Favors Amgen Over TKT; Trial To Focus On Patent Validity

Soluble Human TNF Receptor Allayed Symptoms, Prolonged Life, In Lupus-Emulating Mice

Senate Takes Another Look At Medical Privacy Issues

OraPharma's NDA Accepted For Gum Disease Treatment

Theratechnologies Raising $14M For Itself, $7.3M For Ecopia Unit

Other News To Note